Zachary R Hunter Selected Research

Bone Marrow Diseases (Bone Marrow Disease)

10/2021	Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia.
1/2021	Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia.
5/2017	Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214).
3/2017	Genomics, Signaling, and Treatment of Waldenström Macroglobulinemia.
4/2013	Patients with Waldenström macroglobulinemia commonly present with iron deficiency and those with severely depressed transferrin saturation levels show response to parenteral iron administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zachary R Hunter Research Topics

Disease

59	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022 - 03/2005
19	Neoplasms (Cancer) 11/2021 - 05/2006
14	Lymphoma (Lymphomas) 01/2022 - 01/2007
6	Disease Progression 01/2020 - 03/2010
6	Multiple Myeloma 01/2018 - 03/2011
5	Bone Marrow Diseases (Bone Marrow Disease) 10/2021 - 04/2013
5	Paraproteinemias (Monoclonal Gammopathy) 03/2016 - 08/2007
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2009 - 10/2007
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 01/2018
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2019 - 03/2013
3	Anemia 04/2013 - 01/2009
2	Cardiac Arrhythmias (Arrythmia) 01/2021 - 04/2015
2	Hemorrhage 01/2017 - 04/2015
2	Neutropenia 04/2015 - 07/2014
2	Peripheral Nervous System Diseases (PNS Diseases) 07/2014 - 12/2008
2	Monoclonal Gammopathy of Undetermined Significance 03/2013 - 03/2011
2	Splenomegaly 03/2010 - 03/2005
2	Agammaglobulinemia (Hypogammaglobulinemia) 03/2010 - 06/2008
2	Lymphadenopathy 03/2010 - 03/2005
2	Leukemia 03/2009 - 01/2009
2	Cytopenia 01/2009 - 06/2008
2	type 2C Congenital disorder of glycosylation 12/2008 - 05/2006
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Metrorrhagia (Spotting) 05/2018
1	Exanthema (Rash) 01/2018
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018
1	Melanoma (Melanoma, Malignant) 08/2015
1	Epistaxis (Nosebleed) 04/2015
1	Atrial Fibrillation 04/2015
1	Thrombocytopenia (Thrombopenia) 04/2015
1	Cardiomyopathies (Cardiomyopathy) 07/2014
1	Iron Deficiencies 04/2013
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2011
1	Reinfection 03/2010
1	Fever (Fevers) 03/2009
1	Hemolysis 01/2009
1	Cryoglobulinemia 06/2008

Drug/Important Bio-Agent (IBA)

24	Immunoglobulin M (IgM)IBA 10/2021 - 08/2007
19	ibrutinibIBA 01/2022 - 04/2015
11	Rituximab (Mabthera)FDA Link 01/2020 - 01/2007
5	Bortezomib (Velcade)FDA Link 07/2014 - 06/2007
5	Immunoglobulin G (IgG)IBA 07/2014 - 01/2007
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2007
4	Immunoglobulin A (IgA)IBA 07/2014 - 03/2005
4	Monoclonal AntibodiesIBA 07/2011 - 05/2006
3	venetoclaxIBA 01/2022 - 07/2015
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 08/2013
3	Hemoglobins (Hemoglobin)IBA 10/2021 - 05/2017
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 04/2012
2	idelalisibIBA 01/2017 - 07/2015
2	ParaproteinsIBA 10/2014 - 03/2011
2	Biological ProductsIBA 05/2013 - 08/2007
2	IronIBA 04/2013 - 02/2011
2	HepcidinsIBA 04/2013 - 02/2011
2	EnzymesIBA 04/2012 - 03/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2012 - 03/2009
2	Alemtuzumab (Campath)FDA Link 07/2011 - 05/2006
2	Immunoglobulins (Immunoglobulin)IBA 03/2010 - 01/2007
2	NucleosidesIBA 03/2009 - 01/2009
2	Thalidomide (Thalomid)FDA Link 12/2008 - 08/2007
1	src-Family KinasesIBA 01/2022
1	A 419259IBA 01/2022
1	ulocuplumabIBA 10/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	ChromatinIBA 01/2020
1	Proteasome InhibitorsIBA 01/2020
1	Proto-Oncogene Proteins c-hckIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	ixazomibIBA 01/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018
1	Everolimus FDA Link 05/2017
1	Retinaldehyde (Retinal)IBA 01/2017
1	Fish OilsIBA 04/2015
1	carfilzomibIBA 07/2014
1	Myeloid Differentiation Factor 88IBA 08/2013
1	Transferrin (beta 2 Transferrin)IBA 04/2013
1	pevonedistatIBA 04/2012
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 04/2012
1	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 02/2011
1	Histone Deacetylase InhibitorsIBA 02/2011
1	Metalloproteases (Metalloproteinases)IBA 02/2011
1	Vincristine (Oncovin)FDA LinkGeneric 03/2009
1	nasIBA 01/2009
1	Lenalidomide (CC 5013)FDA Link 01/2009
1	CD40 Ligand (CD40L)IBA 12/2008
1	Simvastatin (Zocor)FDA LinkGeneric 09/2008
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 09/2008
1	Histocompatibility Antigens Class IIBA 06/2008
1	Valine (L-Valine)FDA Link 10/2007
1	Protein Kinase C betaIBA 08/2007
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 08/2007

Therapy/Procedure

16	Therapeutics 01/2021 - 08/2007
1	Oral Administration 11/2021
1	Prostatectomy (Retropubic Prostatectomy) 08/2015
1	Cardiopulmonary Resuscitation (CPR) 03/2009